155 related articles for article (PubMed ID: 34996337)
1. Computational assessment of phytochemicals of medicinal plants from Mexico as potential inhibitors of
Oyedara OO; Fadare OA; Franco-Frías E; Heredia N; García S
J Biomol Struct Dyn; 2023 Mar; 41(5):1776-1789. PubMed ID: 34996337
[TBL] [Abstract][Full Text] [Related]
2. Chlorpromazine and Amitriptyline Are Substrates and Inhibitors of the AcrB Multidrug Efflux Pump.
Grimsey EM; Fais C; Marshall RL; Ricci V; Ciusa ML; Stone JW; Ivens A; Malloci G; Ruggerone P; Vargiu AV; Piddock LJV
mBio; 2020 Jun; 11(3):. PubMed ID: 32487753
[TBL] [Abstract][Full Text] [Related]
3. Virtual high-throughput screening and simulation studies of compounds from selected traditionally important medicinal plants for the identification of potential inhibitors of AcrB.
Puzari M; Chetia P
J Biomol Struct Dyn; 2022 Jul; 40(10):4451-4459. PubMed ID: 33292069
[TBL] [Abstract][Full Text] [Related]
4. Metabolomics Reveal Potential Natural Substrates of AcrB in Escherichia coli and Salmonella enterica Serovar Typhimurium.
Wang-Kan X; Rodríguez-Blanco G; Southam AD; Winder CL; Dunn WB; Ivens A; Piddock LJV
mBio; 2021 Mar; 12(2):. PubMed ID: 33785633
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivatives.
Sjuts H; Vargiu AV; Kwasny SM; Nguyen ST; Kim HS; Ding X; Ornik AR; Ruggerone P; Bowlin TL; Nikaido H; Pos KM; Opperman TJ
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3509-14. PubMed ID: 26976576
[TBL] [Abstract][Full Text] [Related]
6. Discovery of AcrAB-TolC pump inhibitors: Virtual screening and molecular dynamics simulation approach.
Phan TV; Nguyen VT; Nguyen CH; Vu TT; Tran TD; Le MT; Trinh DT; Tran VH; Thai KM
J Biomol Struct Dyn; 2023; 41(22):12503-12520. PubMed ID: 36762699
[TBL] [Abstract][Full Text] [Related]
7. Computational assessment and
Phan TV; Tuong LT; Nguyen VT; Vo CT; Tran TD; Le MT; Nguyen BGD; Tran VT; Vu TT; Thai KM
J Biomol Struct Dyn; 2023 Dec; ():1-13. PubMed ID: 38088368
[TBL] [Abstract][Full Text] [Related]
8. Role of medicinal plants from North Western Himalayas as an efflux pump inhibitor against MDR AcrAB-TolC Salmonella enterica serovar typhimurium: In vitro and In silico studies.
Mehta J; Rolta R; Dev K
J Ethnopharmacol; 2022 Jan; 282():114589. PubMed ID: 34492321
[TBL] [Abstract][Full Text] [Related]
9. Identification of natural compound inhibitors for multidrug efflux pumps of Escherichia coli and Pseudomonas aeruginosa using in silico high-throughput virtual screening and in vitro validation.
Aparna V; Dineshkumar K; Mohanalakshmi N; Velmurugan D; Hopper W
PLoS One; 2014; 9(7):e101840. PubMed ID: 25025665
[TBL] [Abstract][Full Text] [Related]
10. Identification of potential biogenic chalcones against antibiotic resistant efflux pump (AcrB) via computational study.
Rathod S; Dey S; Pawar S; Dhavale R; Choudhari P; Rajakumara E; Mahuli D; Bhagwat D; Tamboli Y; Sankpal P; Mali S; More H
J Biomol Struct Dyn; 2024 Jul; 42(10):5178-5196. PubMed ID: 37340697
[TBL] [Abstract][Full Text] [Related]
11. AcrB drug-binding pocket substitution confers clinically relevant resistance and altered substrate specificity.
Blair JM; Bavro VN; Ricci V; Modi N; Cacciotto P; Kleinekathӧfer U; Ruggerone P; Vargiu AV; Baylay AJ; Smith HE; Brandon Y; Galloway D; Piddock LJ
Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3511-6. PubMed ID: 25737552
[TBL] [Abstract][Full Text] [Related]
12. Molecular Interactions of Carbapenem Antibiotics with the Multidrug Efflux Transporter AcrB of
Atzori A; Malloci G; Cardamone F; Bosin A; Vargiu AV; Ruggerone P
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013182
[TBL] [Abstract][Full Text] [Related]
13.
Samreen ; Qais FA; Ahmad I
J Biomol Struct Dyn; 2023 Apr; 41(6):2189-2201. PubMed ID: 35067192
[TBL] [Abstract][Full Text] [Related]
14. The global consequence of disruption of the AcrAB-TolC efflux pump in Salmonella enterica includes reduced expression of SPI-1 and other attributes required to infect the host.
Webber MA; Bailey AM; Blair JM; Morgan E; Stevens MP; Hinton JC; Ivens A; Wain J; Piddock LJ
J Bacteriol; 2009 Jul; 191(13):4276-85. PubMed ID: 19411325
[TBL] [Abstract][Full Text] [Related]
15. Expression of the marA, soxS, acrB and ramA genes related to the AcrAB/TolC efflux pump in Salmonella enterica strains with and without quinolone resistance-determining regions gyrA gene mutations.
Ferrari RG; Galiana A; Cremades R; Rodríguez JC; Magnani M; Tognim MC; Oliveira TC; Royo G
Braz J Infect Dis; 2013; 17(2):125-30. PubMed ID: 23453941
[TBL] [Abstract][Full Text] [Related]
16. Reversal of the Drug Binding Pocket Defects of the AcrB Multidrug Efflux Pump Protein of Escherichia coli.
Soparkar K; Kinana AD; Weeks JW; Morrison KD; Nikaido H; Misra R
J Bacteriol; 2015 Oct; 197(20):3255-64. PubMed ID: 26240069
[TBL] [Abstract][Full Text] [Related]
17. Molecular dynamics simulation for screening phytochemicals as α-amylase inhibitors from medicinal plants.
Sharma P; Joshi T; Joshi T; Chandra S; Tamta S
J Biomol Struct Dyn; 2021 Oct; 39(17):6524-6538. PubMed ID: 32748738
[No Abstract] [Full Text] [Related]
18. Lack of AcrB Efflux Function Confers Loss of Virulence on
Wang-Kan X; Blair JMA; Chirullo B; Betts J; La Ragione RM; Ivens A; Ricci V; Opperman TJ; Piddock LJV
mBio; 2017 Jul; 8(4):. PubMed ID: 28720734
[TBL] [Abstract][Full Text] [Related]
19. TolC but not AcrB is essential for multidrug-resistant Salmonella enterica serotype Typhimurium colonization of chicks.
Baucheron S; Mouline C; Praud K; Chaslus-Dancla E; Cloeckaert A
J Antimicrob Chemother; 2005 May; 55(5):707-12. PubMed ID: 15814604
[TBL] [Abstract][Full Text] [Related]
20. RamA confers multidrug resistance in Salmonella enterica via increased expression of acrB, which is inhibited by chlorpromazine.
Bailey AM; Paulsen IT; Piddock LJ
Antimicrob Agents Chemother; 2008 Oct; 52(10):3604-11. PubMed ID: 18694955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
